EMD-28850
SARS-CoV-2 Gamma 6P Mut7 S + COVA309-3 Fab
EMD-28850
Single-particle25.0 Å
Deposition: 10/11/2022Map released: 25/10/2023
Last modified: 25/10/2023
Sample Organism:
Homo sapiens
Sample: SARS-CoV-2 Gamma 6P Mut7 S + COVA309-3 Fab
Deposition Authors: Torres JL
,
Ward AB
Sample: SARS-CoV-2 Gamma 6P Mut7 S + COVA309-3 Fab
Deposition Authors: Torres JL
,
Ward AB
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual.
Guerra D ,
Beaumont T,
Radic L ,
Kerster G,
van der Straten K,
Yuan M ,
Torres JL ,
Lee WH,
Liu H,
Poniman M,
Bontjer I,
Burger JA,
Claireaux M,
Caniels TG,
Snitselaar JL,
Bijl TPL,
Kruijer S,
Ozorowski G,
Gideonse D ,
Sliepen K,
Ward AB ,
Eggink D,
de Bree GJ ,
Wilson IA,
Sanders RW,
van Gils MJ
(2023) iScience , 26 , 108009 - 108009
,
Beaumont T,
Radic L ,
Kerster G,
van der Straten K,
Yuan M ,
Torres JL ,
Lee WH,
Liu H,
Poniman M,
Bontjer I,
Burger JA,
Claireaux M,
Caniels TG,
Snitselaar JL,
Bijl TPL,
Kruijer S,
Ozorowski G,
Gideonse D ,
Sliepen K,
Ward AB ,
Eggink D,
de Bree GJ ,
Wilson IA,
Sanders RW,
van Gils MJ
(2023) iScience , 26 , 108009 - 108009
Grant Support:
- Bill & Melinda Gates Foundation: INV-004923 (United States)